Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Hepatobiliary Pancreat Dis Int ; 9(1): 103-6, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20133240

RESUMEN

BACKGROUND: Acinar cell carcinoma (ACC) is a rare malignancy of the pancreas arising from acinar cells. Unlike ductal adenocarcinoma, this tumor rarely presents with pancreatitis. METHODS: We present a case of ACC associated with chronic calcifying pancreatitis, and a review of the literature focusing on diagnosis and management. RESULTS: A 43-year-old man was proposed for Wirsungojejunal derivation for chronic pancreatitis. Histopathological examination of the tissue extracted revealed an ACC. Duodenopancreatectomy was performed. Six months post-operatively, the patient developed hepatic metastasis and was treated with gemcitabine as palliative chemotherapy. CONCLUSIONS: The clinical presentation of ACC of the pancreas is not specific and the tumor can be under-diagnosed when associated with chronic pancreatitis. Data regarding course, treatment, and prognosis of this tumor are generally lacking.


Asunto(s)
Carcinoma de Células Acinares/diagnóstico , Neoplasias Pancreáticas/diagnóstico , Pancreatitis Crónica/complicaciones , Adulto , Carcinoma de Células Acinares/cirugía , Humanos , Masculino , Neoplasias Pancreáticas/cirugía , Pronóstico
2.
Tunis Med ; 87(2): 133-6, 2009 Feb.
Artículo en Francés | MEDLINE | ID: mdl-19522447

RESUMEN

AIM: The aim of this study is to review clinical data, histological and immunohistochemical findings and prognosis of stromal gastrointestinal tumors. METHODS: A retrospective Study of 32 cases of stromal gastrointestinal tumors diagnosed in the Department of Pathology of Mongi Slim Hospital of Tunis from 1991 to 2004. RESULTS: The average age of the patients was of 54.4 years, equal for sex. Tumors were essentially gastric (50%) and of the small intestine (37.5%). All the patients had surgical treatment. Gastro-intestinal Stromal Tumors or GIST represent the most frequent stromal tumor with 56.2% of cases. CONCLUSION: After immunohistochimestry study, using CD117 antigen, this revision allows better management of GIST. Glivec is the standard treatment of advanced GIST.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias Duodenales/metabolismo , Tumores del Estroma Gastrointestinal/metabolismo , Neoplasias del Íleon/metabolismo , Neoplasias del Yeyuno/metabolismo , Proteínas Proto-Oncogénicas c-kit/metabolismo , Neoplasias Gástricas/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos/uso terapéutico , Benzamidas , Neoplasias Duodenales/diagnóstico , Neoplasias Duodenales/tratamiento farmacológico , Neoplasias Duodenales/cirugía , Femenino , Tumores del Estroma Gastrointestinal/diagnóstico , Tumores del Estroma Gastrointestinal/tratamiento farmacológico , Tumores del Estroma Gastrointestinal/cirugía , Humanos , Neoplasias del Íleon/diagnóstico , Neoplasias del Íleon/tratamiento farmacológico , Neoplasias del Íleon/cirugía , Mesilato de Imatinib , Neoplasias del Yeyuno/diagnóstico , Neoplasias del Yeyuno/tratamiento farmacológico , Neoplasias del Yeyuno/cirugía , Masculino , Persona de Mediana Edad , Piperazinas/uso terapéutico , Pirimidinas/uso terapéutico , Estudios Retrospectivos , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/tratamiento farmacológico , Neoplasias Gástricas/cirugía , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA